Avirmax CMC

Avirmax CMC is a spin-off company of Avirmax Inc., headquartered in the San Francisco Bay Area. It is dedicated to the development and manufacturing of rAAV vector-mediated biologics using its proprietary protein therapy and Bac-to-AAV technology. Avirmax CMC Inc. is committed to providing its clients with exceptional transparency, flexibility, and process expertise, as well as high-quality and high-titer AAV vectors, manufacturing capabilities, and regulatory strategy knowledge.